Zelira wins Gov tax refund for cannabinoid research
Biopharma company Zelira Therapeutics has been awarded a $1.2 million cash refund under the Government’s R&D Tax Incentive Scheme, for use on its cannabis-based medical research into autism.
Bod Science R&D supports cannabis absorption
Medicinal cannabis developer, Bod Science, has released the results of the second pharmacokinetic (PK) study for its Aqua Phase drug delivery system. The system has been developed to make water hating (or lipophilic) drugs, such as cannabinoids (CBD), water soluble. The most recent study, according to the company, demonstrated that Aqua Phase delivers six times…
Cann Group doubles sales as CBD use takes off
Medicinal cannabis grower and manufacturer Cann Group has seen sales more than double in the past year as the use of cannabinoid products take off in Australia. The company, which owns a GMP approved production facility at Mildura, Victoria (pictured), said sales revenue for the 12 months to June 2023 was an unaudited $13.5 million,…
Manufacturing news briefs – stories you might have missed
Titomic sells integrated cold spray 3D manufacturing spray booth Additive manufacturing equipment manufacturer Titomic has sold an Integrated Spray Booth system to Dutch firm Perron038 for $710,000. The system incorporates a robotised Titomic D623 medium-pressure cold spray additive manufacturing unit and will be delivered this calendar year. Perron038 is a research and development facilitator that…